{"id":"https://openalex.org/W2913762946","doi":"https://doi.org/10.1016/j.diabres.2019.01.029","title":"Effect of canagliflozin on the overall clinical state including insulin resistance in Japanese patients with type 2 diabetes mellitus","display_name":"Effect of canagliflozin on the overall clinical state including insulin resistance in Japanese patients with type 2 diabetes mellitus","publication_year":2019,"publication_date":"2019-02-01","ids":{"openalex":"https://openalex.org/W2913762946","doi":"https://doi.org/10.1016/j.diabres.2019.01.029","mag":"2913762946","pmid":"https://pubmed.ncbi.nlm.nih.gov/30716347"},"language":"en","primary_location":{"id":"doi:10.1016/j.diabres.2019.01.029","doi":"https://doi.org/10.1016/j.diabres.2019.01.029","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.diabres.2019.01.029","pdf_url":"http://www.diabetesresearchclinicalpractice.com/article/S0168822718315134/pdf","source":{"id":"https://openalex.org/S171311646","display_name":"Diabetes Research and Clinical Practice","issn_l":"0168-8227","issn":["0168-8227","1872-8227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Research and Clinical Practice","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.diabetesresearchclinicalpractice.com/article/S0168822718315134/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108728150","display_name":"Yoko Koike","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Yoko Koike","raw_affiliation_strings":["H.E.C Science Clinic, Yokohama, Japan. Electronic address: y.koike34@gmail.com","H.E.C Science Clinic, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H.E.C Science Clinic, Yokohama, Japan. Electronic address: y.koike34@gmail.com","institution_ids":[]},{"raw_affiliation_string":"H.E.C Science Clinic, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113555639","display_name":"Shinichiro Shirabe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shin-Ichiro Shirabe","raw_affiliation_strings":["H.E.C Science Clinic, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H.E.C Science Clinic, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101911589","display_name":"Hajime Maeda","orcid":"https://orcid.org/0000-0003-0897-1015","observed_orcids":["https://orcid.org/0000-0003-0897-1015"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Hajime Maeda","raw_affiliation_strings":["H.E.C Science Clinic, Yokohama, Japan. Electronic address: nrcbd536@yahoo.co.jp","H.E.C Science Clinic, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H.E.C Science Clinic, Yokohama, Japan. Electronic address: nrcbd536@yahoo.co.jp","institution_ids":[]},{"raw_affiliation_string":"H.E.C Science Clinic, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082013945","display_name":"Ayako Yoshimoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ayako Yoshimoto","raw_affiliation_strings":["H.E.C Science Clinic, Yokohama, Japan. Electronic address: ayahana823@energy.ocn.ne.jp","H.E.C Science Clinic, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H.E.C Science Clinic, Yokohama, Japan. Electronic address: ayahana823@energy.ocn.ne.jp","institution_ids":[]},{"raw_affiliation_string":"H.E.C Science Clinic, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086806876","display_name":"Keiko Arai","orcid":"https://orcid.org/0000-0003-4691-8469","observed_orcids":["https://orcid.org/0000-0003-4691-8469"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Keiko Arai","raw_affiliation_strings":["Arai Clinic, Yokohama, Japan. Electronic address: arai-cl@n04.itscom.net","Arai Clinic, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arai Clinic, Yokohama, Japan. Electronic address: arai-cl@n04.itscom.net","institution_ids":[]},{"raw_affiliation_string":"Arai Clinic, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058327416","display_name":"Atsushi Kumakura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Atsushi Kumakura","raw_affiliation_strings":["Kumakura Clinic, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kumakura Clinic, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034505272","display_name":"Koichi Hirao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Koichi Hirao","raw_affiliation_strings":["H.E.C Science Clinic, Yokohama, Japan. Electronic address: hirao@doc-net.or.jp","H.E.C Science Clinic, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H.E.C Science Clinic, Yokohama, Japan. Electronic address: hirao@doc-net.or.jp","institution_ids":[]},{"raw_affiliation_string":"H.E.C Science Clinic, Yokohama, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088387334","display_name":"Yasuo Terauchi","orcid":"https://orcid.org/0000-0002-8872-3697","observed_orcids":["https://orcid.org/0000-0002-8872-3697"]},"institutions":[{"id":"https://openalex.org/I89630735","display_name":"Yokohama City University","ror":"https://ror.org/0135d1r83","country_code":"JP","type":"education","lineage":["https://openalex.org/I89630735"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yasuo Terauchi","raw_affiliation_strings":["Department of Endocrinology and Metabolism, Yokohama City University School of Medicine, Yokohama, Japan. Electronic address: terauchi-tky@umin.ac.jp","Department of Endocrinology and Metabolism, Yokohama City University School of Medicine, Yokohama, Japan"],"raw_orcid":"https://orcid.org/0000-0002-8872-3697","affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism, Yokohama City University School of Medicine, Yokohama, Japan. Electronic address: terauchi-tky@umin.ac.jp","institution_ids":["https://openalex.org/I89630735"]},{"raw_affiliation_string":"Department of Endocrinology and Metabolism, Yokohama City University School of Medicine, Yokohama, Japan","institution_ids":["https://openalex.org/I89630735"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5034505272","https://openalex.org/A5082013945","https://openalex.org/A5086806876","https://openalex.org/A5088387334","https://openalex.org/A5101911589","https://openalex.org/A5108728150"],"corresponding_institution_ids":["https://openalex.org/I89630735"],"apc_list":{"value":3400,"currency":"USD","value_usd":3400},"apc_paid":{"value":3400,"currency":"USD","value_usd":3400},"fwci":3.2942,"has_fulltext":true,"cited_by_count":48,"citation_normalized_percentile":{"value":0.95629723,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"149","issue":null,"first_page":"140","last_page":"146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":1.0},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":1.0},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8159999847412109},{"id":"https://openalex.org/keywords/visceral-fat","display_name":"visceral fat","score":0.7049999833106995},{"id":"https://openalex.org/keywords/subcutaneous-adipose-tissue","display_name":"subcutaneous adipose tissue","score":0.9350000023841858},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.796999990940094},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.9670000076293945},{"id":"https://openalex.org/keywords/hyperinsulinemic-euglycemic-clamp","display_name":"hyperinsulinemic-euglycemic clamp","score":0.9190000295639038},{"id":"https://openalex.org/keywords/glucose-infusion-rate","display_name":"glucose infusion rate","score":0.8230000138282776},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9648535251617432},{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.9519581198692322},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7331797480583191},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.6959629654884338},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6558123230934143},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5720854997634888},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.44394224882125854}],"mesh":[{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.diabres.2019.01.029","doi":"https://doi.org/10.1016/j.diabres.2019.01.029","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.diabres.2019.01.029","pdf_url":"http://www.diabetesresearchclinicalpractice.com/article/S0168822718315134/pdf","source":{"id":"https://openalex.org/S171311646","display_name":"Diabetes Research and Clinical Practice","issn_l":"0168-8227","issn":["0168-8227","1872-8227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Research and Clinical Practice","raw_type":"journal-article"},{"id":"pmid:30716347","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30716347","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes research and clinical practice","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.diabres.2019.01.029","doi":"https://doi.org/10.1016/j.diabres.2019.01.029","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.diabres.2019.01.029","pdf_url":"http://www.diabetesresearchclinicalpractice.com/article/S0168822718315134/pdf","source":{"id":"https://openalex.org/S171311646","display_name":"Diabetes Research and Clinical Practice","issn_l":"0168-8227","issn":["0168-8227","1872-8227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Research and Clinical Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320327566","display_name":"Mitsubishi Tanabe Pharma Corporation","ror":"https://ror.org/038ehsm73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2913762946.pdf","grobid_xml":"https://content.openalex.org/works/W2913762946.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W147193510","https://openalex.org/W1885872317","https://openalex.org/W1971524892","https://openalex.org/W1975252749","https://openalex.org/W1977023983","https://openalex.org/W1997474721","https://openalex.org/W2022419155","https://openalex.org/W2029480423","https://openalex.org/W2030795765","https://openalex.org/W2031730303","https://openalex.org/W2044432924","https://openalex.org/W2068171948","https://openalex.org/W2104063796","https://openalex.org/W2105912552","https://openalex.org/W2130570549","https://openalex.org/W2150532258","https://openalex.org/W2157405334","https://openalex.org/W2165334726","https://openalex.org/W2166613497","https://openalex.org/W2166823746","https://openalex.org/W2167245776","https://openalex.org/W2169401893","https://openalex.org/W2175616918","https://openalex.org/W2463866167","https://openalex.org/W2742155329","https://openalex.org/W2761135733","https://openalex.org/W2783751304","https://openalex.org/W2804715956","https://openalex.org/W2952155041","https://openalex.org/W2958329191","https://openalex.org/W2977119607"],"related_works":["https://openalex.org/W4323350249","https://openalex.org/W4414642380","https://openalex.org/W1999892123","https://openalex.org/W4211206598","https://openalex.org/W2901946789","https://openalex.org/W2941080913","https://openalex.org/W2793397887","https://openalex.org/W2321592778","https://openalex.org/W2434919988","https://openalex.org/W1558469318"],"abstract_inverted_index":{"AIMS:":[0],"Information":[1],"on":[2,87],"the":[3,10,26,37,88,151],"clinical":[4],"efficacy":[5],"of":[6,17,33,80],"SGLT2":[7],"inhibitors":[8],"in":[9,40,43,124,144,153,186],"Japanese":[11,44,187],"population":[12],"is":[13],"limited.":[14],"The":[15,142],"aim":[16],"this":[18],"single-arm,":[19],"single-center,":[20],"open-label":[21],"study":[22],"was":[23,84,139],"to":[24,168],"confirm":[25],"body":[27,125,155],"weight-":[28],"and":[29,36,57,68,74,109,114,128,133,136,158,181],"fat":[30,130,132,156,160,184],"mass-lowering":[31],"effects":[32],"canagliflozin":[34],"(CANA)":[35],"accompanying":[38],"improvement":[39],"insulin":[41,82,179],"resistance":[42,180],"patients":[45,54,188],"with":[46,150,189],"Type":[47],"2":[48],"diabetes":[49],"mellitus":[50],"(T2DM).":[51],"METHODS:":[52],"Thirty-eight":[53],"were":[55,71],"enrolled":[56],"administered":[58],"100":[59],"mg":[60],"CANA":[61,100,177],"once":[62],"daily":[63],"for":[64],"24":[65],"weeks.":[66],"Blood":[67],"anthropometric":[69],"parameters":[70],"examined":[72],"before":[73],"after":[75],"treatment.":[76],"In":[77,119],"a":[78,94,121],"subset":[79],"patients,":[81],"sensitivity":[83],"assessed":[85],"based":[86],"glucose":[89],"infusion":[90],"rate":[91],"(GIR)":[92],"during":[93],"hyperinsulinemic":[95],"euglycemic":[96],"clamp":[97],"test.":[98],"RESULTS:":[99],"treatment":[101],"significantly":[102,148],"decreased":[103,182],"hemoglobin":[104],"A1c,":[105],"fasting":[106],"plasma":[107,110,116,145],"glucose,":[108],"liver":[111,137],"enzyme":[112],"levels,":[113],"increased":[115,163],"adiponectin":[117,146],"levels.":[118],"addition,":[120],"significant":[122],"reduction":[123],"weight,":[126],"visceral":[127,159,183],"subcutaneous":[129],"area,":[131],"lean":[134],"mass,":[135],"steatosis":[138],"also":[140],"observed.":[141],"change":[143],"levels":[147],"correlated":[149],"changes":[152],"both":[154],"mass":[157,185],"area.":[161],"GIR":[162],"from":[164],"3.25":[165],"\u00b1":[166,170],"1.53":[167],"4.11":[169],"1.30":[171],"mg/kg/min":[172],"(P":[173],"<":[174],"0.05).":[175],"CONCLUSIONS:":[176],"improved":[178],"T2DM.":[190]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-02-21T00:00:00"}